Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06217809 · ClinicalTrials.gov registry record · NA

EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.

A NA study of Abstinence, Sex, sponsored by Alternatives For Girls.

Recruiting
Registry status
NA
Development phase
552
Enrollment target
1
Study location

NCT06217809 is a NA study of Abstinence, Sex that is actively recruiting participants, run by Alternatives For Girls. The registered enrollment target is 552 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06217809, a NA study of Abstinence, Sex, is actively recruiting participants, sponsored by Alternatives For Girls.

RECRUITING
Registry status
NA
Development phase
552 participants
Enrollment target
1
Study location

Study Summary

Alternatives For Girls (AFG's) EmpowHer curriculum is a program for youth who are 10-15 years of age. The curriculum is youth-co-led, and innovative (using online platforms and digitized presentation of material. EmpowHer addresses four adulthood preparation subjects (APS), such as parent-child communication, healthy relationships, adolescent development, and healthy life skills, and can be implemented as an after-school, in/out-of-school-time program.

Conditions Studied

Interventions

  • BEHAVIORAL The intervention curriculum addresses sexual activity, abstinence, and adulthood preparation topics.

Study Locations (1)

Michigan

  • Alternatives For Girls - Detroit

Trial Details

FieldValue
Enrollment Target 552 participants
Start Date 2022-02-22
Est. Completion 2026-09-30
Phase NA

Sponsor

Alternatives For Girls

2 total trials

What the Registry Record Tells You About NCT06217809

The ClinicalTrials.gov registry entry for NCT06217809 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 552 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alternatives For Girls, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Abstinence, Sex appearing as the primary indexed condition, and to 1 intervention - of which The intervention curriculum addresses sexual activity, abstinence, and adulthood preparation topics. is the first listed.

NCT06217809 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT06217809 about?

NCT06217809 is a clinical study titled "EmpowHer is Prevention Curriculum for Youth Ages 10-15 Years.". Alternatives For Girls (AFG's) EmpowHer curriculum is a program for youth who are 10-15 years of age. The curriculum is youth-co-led, and innovative (using online platforms and digitized presentation of material. EmpowHer addresses four adulthood preparation subjects (APS), such as parent-child comm...

What is the current status of trial NCT06217809?

This trial is currently recruiting. It is a NA study. The enrollment target is 552 participants. The study started on 2022-02-22. Estimated completion is 2026-09-30.

What conditions does trial NCT06217809 study?

This clinical trial studies the following conditions: Abstinence, Sex.

What interventions are being tested in trial NCT06217809?

The interventions under investigation include: The intervention curriculum addresses sexual activity, abstinence, and adulthood preparation topics. (BEHAVIORAL).

Who is sponsoring clinical trial NCT06217809?

This trial is sponsored by Alternatives For Girls, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06217809 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.